Vitamin C inhibits corpus gastritis inhelicobacter pylori-infected patients during acid-suppressive therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 11, 2001, Pages 1206-1210

  Yoshinaga, Masahiro ^a,e   Ohtani, Akira ^b   Harada, Naohiko ^c   Fukuda, Yuriko ^d   Nawata, Hajime ^c  

^a Fukuoka Teishin Hospital   (Japan)

^b Chikuho Rosai Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d SRL INC   (Japan)

^e NONE   (United States)

Author keywords

Gastritis; Helicobacter pylori; Interleukin 8; Omeprazole; Vitamin C.

Indexed keywords

ASCORBIC ACID; GASTRIN; INTERLEUKIN 8; OMEPRAZOLE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; DRUG EFFECT; FEMALE; GASTRIN BLOOD LEVEL; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; VITAMIN BLOOD LEVEL;

EID: 0035704040     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02626.x     Document Type: Article

References (23)

1. Campylobacter pylori and peptic ulcer disease
2. Chemokine expression in Helicobacter pylori-infected gastric mucosa
3. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa
4. Expression of interleukin-8 and CD54 by human gastric epithelium after H. pylori infection in vitro
5. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
6. Effect of acid-suppressive therapy on Helicobactor pylori production of interleukin-8 in gastric mucosa
7. NF kappa B and rel proteins: Evolutionarily conserved mediators of immune responses
8. Effect of antioxidative vitamins on immune function with clinical applications
9. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals
10. Classification and grading of gastritis- the updated Sydney System
11. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients
12. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole
13. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia
14. Lack of effect of acid suppression therapy on gastric atrophy
15. Difference in expression of Helicobacter pylori on gastritis in the antrum and body of the stomach
16. Antral atrophy, Helicobacter pylori colonization, and gastric pH
17. Antioxidants in nutrition and their importance in the anti- oxidative balance in the immune system
18. Modulation of interleukin production by ascorbic acid
19. Gastric mucosal damage and adaptive protection by ammonia and ammonium ion in rats
20. Ammonia produced by Helicobacter pylori, related to superoxide generation in situ as a major factor in acute gastritis
21. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: Effects of gastritis and oral supplementation
22. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy
23. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice